Quarterly report pursuant to Section 13 or 15(d)

Accounts Payable and Accrued Liabilities and Compensation (Details)

v3.24.1.u1
Accounts Payable and Accrued Liabilities and Compensation (Details)
$ in Thousands
9 Months Ended 12 Months Ended
Feb. 29, 2024
USD ($)
item
May 31, 2023
USD ($)
item
Accounts Payable and Accrued Liabilities and Compensation    
Accounts payable $ 62,078 $ 62,725
Number of vendors | item 2 2
Compensation and related expense $ 186 $ 335
Legal fees and settlement 112 168
Clinical expense 355 187
Accrued inventory charges and expenses 7,899 4,978
License fees 1,565 862
Lease payable 142 139
Investor proceeds held in escrow 300  
Total accrued liabilities $ 10,559 $ 6,669
Accounts Payable | Credit Availability Concentration Risk | Vendor One    
Accounts Payable and Accrued Liabilities and Compensation    
Concentration risk, percentage 71.00%  
Accounts Payable | Credit Availability Concentration Risk | Vendor Two    
Accounts Payable and Accrued Liabilities and Compensation    
Concentration risk, percentage   72.00%